rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Merit Medical Systems, Inc.

MMSI · Nasdaq

Health CareMedical DevicesLeading

MMSI stood above a rising 150-day average in 9 of the last 52 weekly readings, including each of the last 9 weeks. It is 20.5% above that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−4 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
9 in a row
Industry in uptrend
29% -4 in 4 wk
Insider buys, 12 months
$1.1M
Insider sales, 12 months
$11.7M
Officials’ trades on record
3
Institutions holding
375 (+3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 9 of 52 weeks.

22 Apr – 21 Oct
15%27%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$7.9M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

3 disclosed lines: House 3, Senate 0, executive 0; 2 people.

WhoDidAmountTraded
Lisa C. McClain House: U.S. House ClerkMI09soldspouse$1k–$15k25 Sep 2025filed 22 Oct 2025
Lisa C. McClain House: U.S. House ClerkMI09boughtspouse$1k–$15k22 Jul 2025filed 13 Aug 2025
Steve Chabot House: U.S. House ClerkOH01sold$15k–$50k26 May 2015filed 25 Jun 2015

Insiders

Buy orders, 12 months5
Sale orders, 12 months8
Buyers · sellers5 · 3
WhoDidSharesTraded
Neil W. PetersonCHIEF OPERATING OFFICERsold7,500at $90.4524 Aug 2026filed 25 Aug 2026
Neil W. PetersonCHIEF OPERATING OFFICERsold21,449at $85.004 Aug 2026filed 5 Aug 2026
Christian Adam SmithChief Commercial Officerbought1,626at $61.0011 May 2026filed 13 May 2026
Brian G. LloydCHIEF LEGAL OFFICER, SECRETARYbought2,000at $62.637 May 2026filed 11 May 2026
Lynne N. WardDirectorsold5,000at $62.617 May 2026filed 11 May 2026
Martha Goldberg AronsonPresident and CEObought2,000at $60.446 May 2026filed 7 May 2026
Raul Parra, Jr.CFO AND TREASURERbought1,500at $61.016 May 2026filed 7 May 2026
Michel J. VoigtCHIEF HUMAN RESOURCES OFFICERbought2,250at $60.655 May 2026filed 7 May 2026
Neil W. PetersonCHIEF OPERATING OFFICERsold5,000at $90.006 Jan 2026filed 8 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders375+3 on the quarter
New · exited64 · 61
Reported value$4.3B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20269,464,542$656.3M+630,227+7.1%
VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 20263,473,833$240.9M-49,255−1.4%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 20262,590,454$179.6M-65,709−2.5%
STATE STREET CORPadded · filed 7 Aug 20262,474,512$171.6M+113,530+4.8%
Conestoga Capital Advisors, LLCreduced · filed 24 Jul 20261,979,790$137.3M-187,723−8.7%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20261,625,950$112.8M+117,576+7.8%
FULLER & THALER ASSET MANAGEMENT, INC.reduced · filed 12 Aug 20261,613,002$111.8M-502,524−23.8%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 20261,458,823$101.2M+221,525+17.9%
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.added · filed 14 Aug 20261,279,152$88.7M+80,883+6.7%
CONGRESS ASSET MANAGEMENT COadded · filed 7 Jul 20261,184,337$82.1M+155,088+15.1%
31 Mar 2023 – 30 Jun 2026
228299369Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Sheri Lewis Company insiderEVP of Global Operations · last 4 Sep 20260 · 0
Michel J. Voigt Company insiderCHIEF HUMAN RESOURCES OFFICER · last 24 Aug 20261 · 2
Neil W. Peterson Company insiderCHIEF OPERATING OFFICER · last 24 Aug 20260 · 10
Brian G. Lloyd Company insiderCHIEF LEGAL OFFICER, SECRETARY · last 5 Jun 20261 · 9
Thomas J. Gunderson Company insiderDirector · last 20 May 20260 · 1
F. Ann Ed.D. Millner Company insiderDirector · last 18 May 20260 · 9
Laura S. Kaiser Company insiderDirector · last 18 May 20260 · 0
Lonny J. Carpenter Company insiderDirector · last 18 May 20260 · 0
Lynne N. Ward Company insiderDirector · last 18 May 20260 · 5
Michael R. McDonnell Company insiderDirector · last 18 May 20260 · 2
Scott R. Ward Company insiderDirector · last 18 May 20260 · 0
Silvia M. Perez Company insiderDirector · last 18 May 20260 · 0

Same industry

RCEL Avita MedicalLeading+127%
HTFL HeartflowLeading+59%
ATRC AtriCureLeading+51%
HAE HaemoneticsLeading+44%
BVS BioventusLeading+24%

Distance from each stock’s own 150-day average.

Government contracts

Awards1
Total$21K
Latest18 Jul 2025

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202548.7%
Operating profit marginFY 2025 · to 31 Dec 202512.2%
Free cash flow marginFY 2025 · to 31 Dec 202514.2%
Return on capital employedFY 2025 · to 31 Dec 20257.6%
Cash conversionFY 2025 · to 31 Dec 2025231%
Debt to equityFY 2025 · to 31 Dec 20250.46×
Share count trendFY 2025 · to 20 Feb 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$446.4M
Free cash flowFY 2025 · to 31 Dec 2025$215.7M

Analyst forecasts

No analyst forecasts yet.